glp 1 syringe Pens vs. Needles For Semaglutide Injections Stopping GLP-1 Receptor Agonists… Why

LIXIPARK, published in the New England Journal of Medicine in 2024, was the strongest result to date

Multiple injectable peptidic GLP-1R agonists are approved for the treatment of Type 2 diabetes mellitus (T2DM) ( 8 ), including liraglutide which is also approved for the treatment of obesity ( 9 )

Long wait times

Persons with type 2 diabetes tend to also have some degree of increased body weight or obesity and we know that achieving at least 5% body weight helps to improve glucose and cardiometabolic risk factors. MNT spoke with Jennifer Cheng, DO, chief of endocrinology at Hackensack Meridian Jersey Shore University Medical Center in New Jersey who was not involved in this study who commented it is important to find new options for the treatment of type 2 diabetes and give patients the choice of administering either via subcutaneous injections or just a daily pill

If a hypersensitivity reaction is suspected, discontinue Januvia, assess for other potential causes for the event, and institute alternative treatment for diabetes